Hutchinson-Gilford progeria syndrome (HGPS) is a progeroid disorder characterized by multiple aging-like phenotypes, including disease in large arteries. HGPS is caused by an internally truncated prelamin A (progerin) that cannot undergo the ZMPSTE24-mediated processing step that converts farnesyl-prelamin A to mature lamin A; consequently, progerin retains a carboxyl-terminal farnesyl lipid anchor. In cultured cells, progerin and full-length farnesyl-prelamin A (produced inZmpste24−/−cells) form an abnormal nuclear lamin meshwork accompanied by nuclear membrane ruptures and cell death; however, these proteins differ in their capacity to cause arterial disease. In a mouse model of HGPS (LmnaG609G), progerin causes loss of aortic smooth muscle cells (SMCs) by ~12 weeks of age. In contrast, farnesyl-prelamin A inZmpste24−/−mice does not cause SMC loss—even at 21 weeks of age. In young mice, aortic levels of farnesyl-prelamin A inZmpste24−/−mice and aortic levels of progerin inLmnaG609G/+mice are the same. However, the levels of progerin and other A-type lamins increase with age inLmnaG609G/+mice, whereas farnesyl-prelamin A and lamin C levels inZmpste24−/−mice remain stable.Lmnatranscript levels are similar, implying that progerin influences nuclear lamin turnover. We identified a likely mechanism. In cultured SMCs, the phosphorylation of Ser-404 by AKT (which triggers prelamin A degradation) is reduced in progerin. In mice, AKT activity is significantly lower inLmnaG609G/+aortas than in wild-type orZmpste24−/−aortas. Our studies identify that the accumulation of progerin inLmnaG609Gaortas underlies the hallmark arterial pathology in HGPS.